Clinical Outcomes of Umbilical Cord Blood Transplantation Using Ex Vivo Expansion: A Systematic Review and Meta-Analysis of Controlled Studies
Author:
Funder
Ottawa Hospital Research Institute
Publisher
Elsevier BV
Subject
Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy
Reference27 articles.
1. Umbilical cord blood: counselling, collection, and banking;Armson;J Obstet Gynaecol Can,2015
2. Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling;Locatelli;Blood,2013
3. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources;Rocha;N Engl J Med,2000
4. Similar overall survival using sibling, unrelated donor, and cord blood grafts after reduced-intensity conditioning for older patients with acute myelogenous leukemia;Peffault de Latour;Biol Blood Marrow Transplant,2013
5. Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome;Tomblyn;J Clin Oncol,2009
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Umbilical cord blood derived cell expansion: a potential neuroprotective therapy;Stem Cell Research & Therapy;2024-07-29
2. Donor selection in allogeneic stem cell transplantation;Current Opinion in Hematology;2024-07-16
3. Advances in ex vivo expansion of hematopoietic stem and progenitor cells for clinical applications;Frontiers in Bioengineering and Biotechnology;2024-05-23
4. Impact of lower concentrations of dimethyl sulfoxide on cryopreservation of autologous hematopoietic stem cells: a systematic review and meta-analysis of controlled clinical studies;Cytotherapy;2024-05
5. A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2023;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-03-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3